Dcs
Pain Syndrome
Leiden University Medical CenterN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Pain Syndrome cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
DEXAMETHASONE Ottawa Hospital Research Institute | Phase 4 | BB |
Adezunap Apurano Pharmaceuticals GmbH | Phase 3 | B |
TRIATOMIC OXYGEN Bernardino Clavo, MD, PhD | Phase 2/3 | B |
Marijuana University of California, San Diego | Phase 2 | B |
Oxygen Bernardino Clavo, MD, PhD | Phase 2/3 | B |
View all 10 →
Same molecule, other indications
Dcs is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →